Not every stock caught in a market-wide selloff deserves to be there, and Jim Cramer thinks investors are lumping one particular chipmaker in with names it does not really belong next to. His argument arrived in the middle of a genuinely rough time for AI stocks broadly, which made the timing of his pitch nearly impossible to ignore.

Sometimes the best investing advice is also the shortest. A caller phoned into a popular financial show asking a question thousands of investors have probably typed into a search bar at some point this year. The answer came back almost instantly, with no hedging attached.

An old Wall Street adage just got a fresh test.

Stocks fell on September 10 after U.S. oil prices topped $100 a barrel for the first time in months. The move spooked markets. Inflation fears came back. And one of the most watched voices on financial television went on air with a specific message about what investors should actually be focused on.

Jim Cramer openly shares his opinions about various stocks, and on September 3, 2026, during an episode of CNBC’s Mad Money, he gave his two cents on Nuvation Bio (NUVB).